Shenzhen Kangtai Biological Products Co. Ltd.

Shenzhen Kangtai Biologics develops and sells a broad portfolio of human vaccines—including 13‑valent pneumococcal, hepatitis B, rabies, and Covid‑19—in China, with a joint venture in Malaysia to expand its COVID‑19 product line.

Headquarters: China (CHN)

Website: Visit Site 🔗
Type: Corporation

Company Profile

Sector: Manufacturing
Industry: Pharmaceutical Manufacturing

Employees: 1,913
HQ: Shenzhen

Unlock the full potential.

Get access to Relative P/E Ratio Valuation Histogram.

Upgrade

Traded Instruments

+ Add Instrument 1

Symbol	Name	Type	Exchange	Currency	ISIN	Status	Actions
300601	Shenzhen Kangtai Biological Products Co. Ltd. Cap: 17.8B	EQUITY	SHZ	CNY	CNE100002Q33	Active	📈